GST-HG141 Placebo

DRUG2 trials

Sponsors

Fujian Akeylink Biotechnology Co., Ltd.

Conditions

Chronic Hepatitis BChronic Hepatitis b

Phase 2

Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B

RecruitingNCT07709520

Fujian Akeylink Biotechnology Co., Ltd.Chronic Hepatitis B

Start: 2026-07-10End: 2026-12-01Target: 80Updated: 2026-07-17

Phase 3

To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment

RecruitingNCT07090759

Fujian Akeylink Biotechnology Co., Ltd.Chronic Hepatitis b

Start: 2025-07-24End: 2027-03-01Target: 526Updated: 2026-01-23